Navigation Links
Verenium Appoints Kevin Bracken Vice President of Manufacturing
Date:8/26/2010

CAMBRIDGE, Mass., Aug. 26 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced the appointment of Kevin Bracken to the position of Vice President of Manufacturing. Bracken will report to Janet Roemer, President and Chief Operating Officer of Verenium's Enzymes Business.

"Kevin brings over 30 years of valuable manufacturing experience from global biotechnology companies," said Roemer.  "His extensive background in manufacturing leadership and breadth of expertise in process engineering, facilities and equipment design, project management, contract manufacturing, and commercial scale-up of novel products will greatly benefit Verenium as we work to optimize and expand our manufacturing capabilities."

Prior to joining Verenium, Bracken was Vice President of Manufacturing at Vical Incorporated, a developer of biopharmaceutical products, where he was responsible for all manufacturing activities, served on numerous product development, validation and technical teams for new product candidates, and supervised all scale-up and optimization operations for the company.

Previously, Bracken was Vice President of Process Engineering and Manufacturing at Universal Preservation Technologies, Inc., and was Director of Engineering for Molecular Biosystems. Prior to that, he held positions of increasing responsibility in process engineering with Gilead Sciences and Baxter International.  He began his career as an engineer with DuPont.

Bracken received a B.S. in Chemical Engineering from the University of Delaware and a M.S. in Chemical Engineering from the University of Rochester.

About VereniumVerenium Corporation is a pioneer in the development and commercialization of high-performance enzymes for use in industrial processes. &
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Verenium Announces Proposed Public Offering of Common Stock
2. Verenium 1:12 Reverse Stock Split Takes Effect
3. Verenium Announces Reverse Stock Split to Take Effect September 9
4. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
5. Verenium Completes Amendment to 8% Senior Convertible Notes
6. Verenium Announces Organizational Changes
7. Verenium Announces First Commercial Cellulosic Ethanol Project
8. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
9. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
10. Verenium Corporation to Announce Third Quarter 2008 Financial Results
11. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 The ... encourage all types of inventions. They focus on learning ... noticing this community gravitate toward bringing their ideas to ... DIY Biology Movement, works on making projects using biology. ... DNA of plants to make them glow with bioluminescence ...
(Date:5/23/2013)... 2013 Virobay, Inc. today announced that their ... an important milestone, as Virobay has now initiated a ... cathepsin S inhibitor.   The first Phase ... study designed to evaluate the safety, tolerability, pharmacokinetics and ... "The initiation of this Phase 1 trial ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... During the conduct of research involving ... principles of good clinical practice (GCP) and human ... Lim, Fellow, Clinical Development at Novartis Pharmaceuticals, will ... the International Conference on Harmonization (ICH) Guideline for ... the conduction of clinical trials ,     Apply ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
... New Jersey, November 26, Rosetta Genomics (Nasdaq: ... results on December 5, 2008, before the,U.S. markets open. ... webcast to discuss these results at 8:30 a.m. ET ... To access the live conference call, U.S. and ...
... MENLO PARK, Calif., Nov. 26 Evalve, Inc., ... percutaneous repair of cardiac valves,announced today that the ... MitraClip(R) system at the University of Hull, Castle ... is the first commercially,available medical device which provides ...
... 26 Aldrich, a division of,Sigma-Aldrich (Nasdaq: ... Science catalog. The catalog features more than 4,000 ... Ceramic Science,Nanomaterials, Micro/NanoElectronics and Polymer Science. Each chapter,contains ... advances,in these fields. , ...
Cached Biology Technology:Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results 2First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 2First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 3Aldrich(R) Releases Materials Science Catalog That Includes Products to Advance Sustainable Energy and Nanotechnology Research 2
(Date:5/23/2013)... the new mechanism by which estrogen suppresses lipid synthesis ... potential new approach toward treating certain liver diseases. ... believe they are changing long-held views in the field. ... the journal Science Signaling . , "The dogma ... been that only receptors located in the nucleus respond ...
(Date:5/23/2013)... WASHINGTON Given the implications for the overall ... should play a primary role in ensuring that ... least 60 minutes per day of vigorous or ... the Institute of Medicine. Recent estimates suggest ... this evidence-based guideline for promoting better health and ...
(Date:5/23/2013)... A new report from the Institute of Medicine says ... at least 60 minutes of vigorous or moderate intensity ... half of American youth meet current evidence-based guidelines of ... physical activity daily, according to the report, which was ... for nearly half of their waking hours, the committee ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3Schools should provide students with daily physical activity, IOM recommends 2
... might one day avoid the prospect of invasive breast ... involve using stem cells derived from their own fat, ... potential these cells may have for regenerating new breast ... to prove that an injection of fat-derived stem cells ...
... bees, neuropeptides control brain activity and, hence, our behaviors. Understanding ... honey bee will assist researchers in understanding the roles they ... neurons in the brain of a honey bee (Apis mellifera), ... period at the end of this sentence. The activities of ...
... covering almost half the animal species on the planet has ... relationships between four major groups of insects. , ... related to beetles and more distantly related to bees and ... are published in the special Honey Bee Genome issue of ...
Cached Biology News:Fat stem cells being studied as option for breast reconstruction 2Scientists identify 36 genes, 100 neuropeptides in honey bee brains 2New genetic analysis forces re-draw of insect family tree 2
... ImageXpress 5000A automated cellular imaging and analysis ... system designed specifically for rapid acquisition and ... cell-based screening. ImageXpress is fast. Scanning ... (1280 x 1024 pixels), with two fluorescence ...
... joined forces with the Mickle Laboratory Engineering ... Chopper. This tissue sectioning system has been ... metabolic experiments and to be especially applicable ... biopsy or from small organs. Its special ...
... a new product number, created to ... showing no availability yet, please order ... or contact customer service for assistance. ... easy grip) Mfr Desig: ...
... fluorescence scanner with 1 or 2 color(s), ... CGH, ) spotted on standard slides combining ... scanners include three different models:, ... dual fluorescence scanner (635nm and 532nm). , ...
Biology Products: